Temat: "psoriasis" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Ixekizumab treatment patterns and healthcare utilization and costs for patients with psoriasis.
Autorzy :: Murage MJ; Eli Lilly and Company, Indianapolis, IN, USA.
Gilligan AM; ConcertoHealthAI, Fort Worth, TX, USA.
Tran O; IBM Watson Health, Cambridge, MA, USA.
Goldblum O; Eli Lilly and Company, Indianapolis, IN, USA.
Burge R; Eli Lilly and Company, Indianapolis, IN, USA.; University of Cincinnati, Cincinnati, OH, USA.
Lin CY; Eli Lilly and Company, Indianapolis, IN, USA.
Qureshi A; The Warren Alpert Medical School of Brown University, Providence, RI, USA.; Pokaż więcej
Źródło :: The Journal of dermatological treatment [J Dermatolog Treat] 2021 Feb; Vol. 32 (1), pp. 56-63. Date of Electronic Publication: 2019 Nov 20.
Typ publikacji :: Journal Article
MeSH Terms :: Health Care Costs*
Patient Acceptance of Health Care*
Antibodies, Monoclonal, Humanized/*therapeutic use
Dermatologic Agents/*therapeutic use
Psoriasis/*drug therapy
Adult ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Outcome Assessment, Health Care ; Psoriasis/pathology ; Psoriasis/psychology ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: A systematic review of treatment strategies for erythrodermic psoriasis.
Autorzy :: Reynolds KA; Univeristy of Cincinnati College of Medicine, Cincinnati, OH, USA.
Pithadia DJ; Medical College of Georgia, Augusta University, Augusta, GA, USA.
Lee EB; Department of Medicine, Santa Barbara Cottage Hospital, Santa Barbara, CA, USA.
Liao W; Department of Dermatology, University of San Francisco, San Francisco, CA, USA.
Wu JJ; Dermatology Research and Education Foundation, Irvine, CA, USA.; Pokaż więcej
Źródło :: The Journal of dermatological treatment [J Dermatolog Treat] 2021 Feb; Vol. 32 (1), pp. 49-55. Date of Electronic Publication: 2019 Nov 12.
Typ publikacji :: Journal Article; Systematic Review
MeSH Terms :: Antibodies, Monoclonal/*therapeutic use
Dermatologic Agents/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Psoriasis/*drug therapy
Dermatitis, Exfoliative/complications ; Humans ; Interleukin-17/antagonists & inhibitors ; Interleukin-17/metabolism ; Psoriasis/complications ; Treatment Outcome ; Tumor Necrosis Factor-alpha/antagonists & inhibitors ; Tumor Necrosis Factor-alpha/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: [John Updikes "War with his skin"].
Autorzy :: Barth J; Leipzig, Deutschland.
Barth D; Hautarztpraxis Borna, Rudolf-Virchow-Str. 4, 04552, Borna, Deutschland. .; Pokaż więcej
Transliterated Title :: John Updikes „Krieg mit seiner Haut“.
Źródło :: Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete [Hautarzt] 2021 Feb; Vol. 72 (2), pp. 181-182.
Typ publikacji :: Journal Article
MeSH Terms :: Psoriasis*/diagnosis
Psoriasis*/therapy
Skin*
Humans ; Phototherapy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study.
Autorzy :: Talamonti M; Dermatology Department, University of Rome 'Tor Vergata' , Rome, Italy.
Galluzzo M; Dermatology Department, University of Rome 'Tor Vergata' , Rome, Italy.
Chiricozzi A; Fondazione Policlinico Universitario A. Gemelli IRCCS, Dermatologia, Dipartimento Scienze Mediche e Chirurgiche , Rome, Italy.; Università Cattolica del Sacro Cuore, Dermatologia , Rome, Italy.
Quaglino P; Medical Sciences Department, Dermatologic Clinic, University of Turin , Turin, Italy.
Fabbrocini G; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II , Naples, Italy.
Gisondi P; Section of Dermatology and Venereology, Department of Medicine, University of Verona , Verona, Italy.
Marzano AV; Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico , Milan, Italy.; Department of Pathophysiology and Transplantation, Università Degli Studi di Milano , Milan, Italy.
Potenza C; Department of Medico-Surgical Sciences and Biotechnologies, Dermatology Unit 'Daniele Innocenzi' Sapienza University of Rome - Polo Pontino , Rome, Italy.
Conti A; Dermatologic Unit, Department of Specialized Medicine, AOU Policlinico di Modena , Modena, Italy.
Parodi A; Clinica Dermatologica DiSSal Università di Genova, Ospedale-Policlinico San Martino IRCCS Genova , Italy.
Piaserico S; Dermatology Unit - Department of Medicine DIMED, University of Padova , Padova, Italy.
Bardazzi F; Dermatology Division, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna , Bologna, Italy.
Argenziano G; Dermatology Unit, University of Campania Luigi Vanvitelli , Naples, Italy.
Rongioletti F; Section of Dermatology, Department of Medical Sciences and Public Health, University of Cagliari , Cagliari, Italy.
Stingeni L; Dermatology Section, Department of Medicine, University of Perugia , Perugia, Italy.
Micali G; Dermatology Clinic, University of Catania , Catania, Italy.
Loconsole F; Department of Biomedical Science and Human Oncology, Unit of Dermatology, University of Bari , Bari, Italy.
Rossi MT; Department of Dermatology, ASST Spedali Civili of Brescia, University of Brescia , Brescia, Italy.
Bongiorno MR; Section of Dermatology, Department of Health Promotion, Maternal-Infant, Internal Medicine and Specialization, University of Palermo , Palermo, Italy.
Feliciani C; Department of Medicine and Surgery, Section of Dermatology, University of Parma , Parma, Italy.
Rubegni P; Dermatology Unit, Department of Medical, Surgical and Neurosciences, University of Siena , Siena, Italy.
Amerio P; Department of Medicine and Aging Science, Dermatologic Clinic, G. D'Annunzio University , Chieti, Italy.
Fargnoli MC; Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila , L'Aquila, Italy.
Pigatto P; Department of Biomedical, Surgical and Dental Sciences, Clinical Dermatology, IRCCS Galeazzi Orthopaedic Institute, University of Milan , Milan, Italy.
Savoia P; Department of Health Science, Dermatologic Clinic, University of Eastern Piedmont , Novara, Italy.
Nisticò SP; Dermatology Unit, Department of Health Sciences, Università Magna Graecia , Catanzaro, Italy.
Giustini S; Department of Dermatology, 'Sapienza' University of Rome , Rome, Italy.
Carugno A; Dermatology Unit, ASST Papa Giovanni XXIII Hospital , Bergamo, Italy.
Cannavo' SP; Dermatology, Department of Clinical and Experimental Medicine, University of Messina , Messina, Italy.
Rech G; Division of Dermatology, Santa Chiara Hospital , Trento, Italy.
Prignano F; Dermatology Clinic, Department of Health Sciences, University of Florence , Florence, Italy.
Offidani A; Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of the Marche Region , Ancona, Italy.
Lombardo M; Unit of Dermatological Diseases, ASST Sette Laghi, Ospedale di Circolo , Varese, Italy.
Zalaudek I; Department of Dermatology, University of Trieste , Trieste, Italy.
Bianchi L; Dermatology Department, University of Rome 'Tor Vergata' , Rome, Italy.
Peris K; Fondazione Policlinico Universitario A. Gemelli IRCCS, Dermatologia, Dipartimento Scienze Mediche e Chirurgiche , Rome, Italy.; Università Cattolica del Sacro Cuore, Dermatologia , Rome, Italy.; Pokaż więcej
Źródło :: Expert opinion on biological therapy [Expert Opin Biol Ther] 2021 Feb; Vol. 21 (2), pp. 271-277. Date of Electronic Publication: 2021 Jan 13.
Typ publikacji :: Journal Article; Multicenter Study; Observational Study
MeSH Terms :: Biological Products/*therapeutic use
Biological Therapy/*methods
COVID-19/*epidemiology
Psoriasis/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Biological Products/pharmacology ; COVID-19/diagnosis ; Chronic Disease ; Cohort Studies ; Female ; Humans ; Incidence ; Interleukin-17/antagonists & inhibitors ; Italy/epidemiology ; Male ; Middle Aged ; Pandemics ; Psoriasis/diagnosis ; Psoriasis/epidemiology ; Receptors, Interleukin/antagonists & inhibitors ; Risk Assessment/methods ; Tumor Necrosis Factor-alpha/antagonists & inhibitors ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Interleukin-36: Structure, Signaling and Function.
Autorzy :: Zhou L; AbbVie Bioresearch Center, Worcester, MA, USA. .
Todorovic V; AbbVie Inc., North Chicago, IL, USA.; Pokaż więcej
Źródło :: Advances in experimental medicine and biology [Adv Exp Med Biol] 2021; Vol. 21, pp. 191-210.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Interleukin-1*/genetics
Psoriasis*/genetics
Animals ; Interleukin-1 Receptor Accessory Protein ; Interleukins ; Mice ; Skin
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: New generation biologics for the treatment of psoriasis and psoriatic arthritis. State of the art and considerations about the risk of infection.
Autorzy :: Ceccarelli M; Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.; Department of Biomedical and Dental Sciences and Morpho Functional Imaging, University of Messina, Messina, Italy.
Venanzi Rullo E; Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Berretta M; Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Cacopardo B; Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
Pellicanò GF; Department of Adult and Childhood Human Pathology 'Gaetano Barresi', University of Messina, Messina, Italy.
Nunnari G; Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Guarneri C; Department of Biomedical and Dental Sciences and Morpho Functional Imaging, University of Messina, Messina, Italy.; Pokaż więcej
Źródło :: Dermatologic therapy [Dermatol Ther] 2021 Jan; Vol. 34 (1), pp. e14660. Date of Electronic Publication: 2020 Dec 25.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Arthritis, Psoriatic*/diagnosis
Arthritis, Psoriatic*/drug therapy
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Biological Products/*therapeutic use
Biological Products/adverse effects ; Humans ; Inflammation ; Skin
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: The impact of COVID-19 in patients with psoriasis: A multicenter study in Istanbul.
Autorzy :: Kara Polat A; Department of Dermatology, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, Turkey.
Oguz Topal I; Department of Dermatology, Prof. Dr. Cemil Taşçıoğlu City Hospital, Istanbul, Turkey.
Karadag AS; Department of Dermatology, Istanbul Medeniyet University, Faculty of Medicine, Goztepe Training and Research Hospital, Istanbul, Turkey.
Aksoy H; Department of Dermatology, Istanbul Medeniyet University, Faculty of Medicine, Goztepe Training and Research Hospital, Istanbul, Turkey.
Koku Aksu AE; Department of Dermatology, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, Turkey.
Ozkur E; Department of Dermatology, University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Ozkok Akbulut T; Department of Dermatology, University of Health Sciences, Haseki Training and Research Hospital, Istanbul, Turkey.
Topaloglu Demir F; Department of Dermatology, Istanbul Medipol University, Faculty of Medicine, Istanbul, Turkey.
Engin B; Department of Dermatology, Istanbul University-Cerrahpasa, Faculty of Medicine, Istanbul, Turkey.
Uzuncakmak TK; Department of Dermatology, Istanbul University-Cerrahpasa, Faculty of Medicine, Istanbul, Turkey.
Kıvanc Altunay I; Department of Dermatology, University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.; Pokaż więcej
Źródło :: Dermatologic therapy [Dermatol Ther] 2021 Jan; Vol. 34 (1), pp. e14691. Date of Electronic Publication: 2020 Dec 30.
Typ publikacji :: Journal Article; Multicenter Study
MeSH Terms :: COVID-19*/complications
Psoriasis*/diagnosis
Psoriasis*/epidemiology
Psoriasis*/etiology
Psoriasis*/therapy
Adult ; Female ; Humans ; Male ; Middle Aged ; Pandemics ; SARS-CoV-2
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Surveillance of psoriatic patients on biologic treatment during the COVID-19 pandemic: A single-center experience.
Autorzy :: Polat Ekinci A; Department of Dermatology and Venereology, Istanbul University Medicine Faculty, Istanbul, Turkey.
Pehlivan G; Department of Dermatology and Venereology, Istanbul University Medicine Faculty, Istanbul, Turkey.
Gökalp MO; Department of Dermatology and Venereology, Istanbul University Medicine Faculty, Istanbul, Turkey.; Pokaż więcej
Źródło :: Dermatologic therapy [Dermatol Ther] 2021 Jan; Vol. 34 (1), pp. e14700. Date of Electronic Publication: 2020 Dec 28.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Psoriasis*/epidemiology
Biological Products/*therapeutic use
Adult ; Biological Products/adverse effects ; Humans ; Middle Aged ; Pandemics ; SARS-CoV-2 ; Turkey/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Retention and survival rate of etanercept in psoriasis over 15 years and patient outcomes during the COVID-19 pandemic: The real-world experience of a single center.
Autorzy :: Onsun N; Department of Dermatology and Venereology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Güneş B; Department of Dermatology and Venereology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Yabacı A; Department of Bioistatistics, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.; Pokaż więcej
Źródło :: Dermatologic therapy [Dermatol Ther] 2021 Jan; Vol. 34 (1), pp. e14623. Date of Electronic Publication: 2020 Dec 11.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Psoriasis*/epidemiology
Etanercept/*therapeutic use
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Etanercept/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Obesity, Morbid ; Pandemics ; SARS-CoV-2 ; Severity of Illness Index ; Survival Rate ; Treatment Outcome ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Immunosuppressive drugs for patients with psoriasis during the COVID-19 pandemic era. A review.
Autorzy :: Sadeghinia A; Department of Dermatology, Razi Dermatology Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Daneshpazhooh M; Department of Dermatology, Razi Dermatology Hospital, Tehran University of Medical Sciences, Tehran, Iran.; Pokaż więcej
Źródło :: Dermatologic therapy [Dermatol Ther] 2021 Jan; Vol. 34 (1), pp. e14498. Date of Electronic Publication: 2020 Nov 10.
Typ publikacji :: Journal Article; Review
MeSH Terms :: COVID-19*
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Psoriasis*/epidemiology
Immunosuppressive Agents/*therapeutic use
Humans ; Immunosuppressive Agents/adverse effects ; Pandemics ; SARS-CoV-2
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.
Autorzy :: Mahil SK; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom.
Dand N; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom; Health Data Research UK, London, United Kingdom.
Mason KJ; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, National Institute for Health Research Manchester Biomedical Research Centre, Manchester, United Kingdom.
Yiu ZZN; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, National Institute for Health Research Manchester Biomedical Research Centre, Manchester, United Kingdom.
Tsakok T; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom.
Meynell F; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom.
Coker B; National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
McAteer H; The Psoriasis Association, Northampton, United Kingdom.
Moorhead L; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom.
Mackenzie T; Dermatology Department, Churchill Hospital, Oxford, United Kingdom.
Rossi MT; Dermatology Department, Spedali Civili Hospital, Brescia, Italy.
Rivera R; Dermatology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain.
Mahe E; Department of Dermatology, Hôpital Victor Dupouy, Argenteuil, France; Groupe de recherche sur le psoriasis (GrPso) de la Société Française de Dermatologie, Paris, France.
Carugno A; Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.
Magnano M; Dermatology Unit, Santa Chiara Hospital, Trento, Italy.
Rech G; Dermatology Unit, Santa Chiara Hospital, Trento, Italy.
Balogh EA; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC.
Feldman SR; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC.
De La Cruz C; Clinica Dermacross, Santiago, Chile.
Choon SE; Jeffrey Cheah School Of Medicine and Health Sciences, Monash University, Subang Jaya, Selangor.
Naldi L; Centro Studi GISED, Bergamo, Italy.
Lambert J; Department of Dermatology, Ghent University, Ghent, Belgium.
Spuls P; Department of Dermatology, Amsterdam Public Health/Infection and Immunology, Amsterdam University Medical Centers, Location AMC, Amsterdam, The Netherlands.
Jullien D; Groupe de recherche sur le psoriasis (GrPso) de la Société Française de Dermatologie, Paris, France; Department of Dermatology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.
Bachelez H; Department of Dermatology, AP-HP Hôpital Saint-Louis, Paris, France; INSERM U1163, Imagine Institute for Human Genetic Diseases, Université de Paris, Paris, France.
McMahon DE; Harvard Medical School, Boston, Mass.
Freeman EE; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.
Gisondi P; Section of Dermatology and Venereology, University of Verona, Verona, Italy.
Puig L; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, National Institute for Health Research Manchester Biomedical Research Centre, Manchester, United Kingdom.
Di Meglio P; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
Langan SM; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom; Faculty of Epidemiology, and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Capon F; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
Griffiths CEM; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, National Institute for Health Research Manchester Biomedical Research Centre, Manchester, United Kingdom.
Barker JN; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
Smith CH; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom. Electronic address: .; Pokaż więcej
Corporate Authors :: PsoProtect study group
Źródło :: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2021 Jan; Vol. 147 (1), pp. 60-71. Date of Electronic Publication: 2020 Oct 16.
Typ publikacji :: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :: COVID-19*/mortality
COVID-19*/therapy
Hospitalization*
Psoriasis*/mortality
Psoriasis*/therapy
Registries*
SARS-CoV-2*
Adult ; Age Factors ; Female ; Humans ; Male ; Middle Aged ; Risk Factors ; Sex Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Optimizing care for psoriatic patients requiring systemic therapies: how will COVID-19 disease transform risk perceptions?
Autorzy :: Talamonti M; Dermatology Unit, Fondazione Policlinico Tor Vergata, Rome, Italy. .; Department of Systems Medicine, University of Rome 'Tor Vergata', Rome, Italy. .
Tofani L; Dermatology Unit, Fondazione Policlinico Tor Vergata, Rome, Italy.; Department of Systems Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Bianchi L; Dermatology Unit, Fondazione Policlinico Tor Vergata, Rome, Italy.; Department of Systems Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Galluzzo M; Dermatology Unit, Fondazione Policlinico Tor Vergata, Rome, Italy.; Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.; Pokaż więcej
Źródło :: Archives of dermatological research [Arch Dermatol Res] 2021 Mar; Vol. 313 (2), pp. 127-128. Date of Electronic Publication: 2020 Jul 09.
Typ publikacji :: Letter
MeSH Terms :: Practice Guidelines as Topic*
COVID-19/*complications
Cytokine Release Syndrome/*prevention & control
Psoriasis/*drug therapy
Withholding Treatment/*standards
Anti-Inflammatory Agents, Non-Steroidal/adverse effects ; Biological Factors/administration & dosage ; Biological Factors/adverse effects ; COVID-19/epidemiology ; COVID-19/immunology ; COVID-19/virology ; Clinical Decision-Making ; Comorbidity ; Cytokine Release Syndrome/immunology ; Dermatology/standards ; Dose-Response Relationship, Drug ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Patient Selection ; Psoriasis/epidemiology ; Psoriasis/immunology ; Risk Assessment ; Risk Factors ; SARS-CoV-2/immunology ; Societies, Medical/standards ; Thalidomide/administration & dosage ; Thalidomide/adverse effects ; Thalidomide/analogs & derivatives
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Recommendations for psoriatic arthritis management: A joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology.
Autorzy :: Tsai TF; Department of Dermatology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan.
Hsieh TY; Division of Allergy-Immunology-Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan; Program of Business, College of Business, Feng Chia University, Taichung, Taiwan.
Chi CC; Department of Dermatology, Chang Gung Memorial Hospital-Linkou, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Chou CT; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Hsieh LF; Department of Physical Medicine and Rehabilitation, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan; School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
Chen HH; Division of Allergy-Immunology-Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan.
Hui RC; Department of Dermatology, Chang Gung Memorial Hospital-Linkou, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Dermatology, Chang Gung Memorial Hospital-Keelung, Keelung, Taiwan.
Lee CH; College of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Dermatology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Liu CH; Division of Allergy, Immunology and Rheumatology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan; School of Medicine, Tzu Chi University, Hualien, Taiwan.
Liu HC; Department of Orthopedic Surgery, National Taiwan University Hospital, Taipei, Taiwan; Department of Orthopedics Surgery, Taiwan Adventist Hospital, Taipei, Taiwan.
Yeo KJ; Division of Rheumatology and Immunology, China Medical University Hospital, Taichung, Taiwan.
Chen CH; Division of Allergy, Immunology and Rheumatology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
Chen HA; Department of Allergy, Immunology, and Rheumatology, Chi Mei Medical Center, Tainan, Taiwan.
Chen YC; Department of Rheumatology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Chen YJ; Department of Dermatology, Taichung Veterans General Hospital, Taichung, Taiwan.
Chiu HY; Department of Dermatology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan; Department of Dermatology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
Ho JC; College of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Dermatology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Department of Dermatology, Chang Gung Memorial Hospital-Chiayi, Chiayi, Taiwan.
Huang YH; Department of Dermatology, Chang Gung Memorial Hospital-Linkou, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Lai PJ; Division of Dermatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
Lee WR; Department of Dermatology, Taipei Medical University Shuang Ho Hospital, Taipei, Taiwan; Department of Dermatology, School of Medicine, Taipei Medical University, Taipei, Taiwan; Graduate Institute of Medical Science, Taipei Medical University, Taipei, Taiwan.
Liao HT; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.
Lin SH; College of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Dermatology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Tseng JC; Division of Allergy, Immunology, and Rheumatology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Wang TS; Department of Dermatology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan; Division of Dermatology, Chung Shan Medical University Hospital, Taichung, Taiwan; Department of Dermatology, Chung Shan Medical University, Taichung, Taiwan.
Wu NL; Department of Dermatology, MacKay Memorial Hospital, Taipei, Taiwan; Department of Medicine, MacKay Medical College, New Taipei City, Taiwan.
Yang DH; Division of Rheumatology/Immunology/Allergy, Department of Internal Medicine, Taichung Armed-Forces General Hospital, Taichung, Taiwan; Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taichung, Taiwan; Division of Rheumatology/Immunology/Allergy, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Tsai WC; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Wei JC; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan; Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan. Electronic address: .; Pokaż więcej
Corporate Authors :: Taiwan Rheumatology Association (TRA) and the Taiwanese Association for Psoriasis and Skin Immunology (TAPSI)
Źródło :: Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2021 Mar; Vol. 120 (3), pp. 926-938. Date of Electronic Publication: 2020 Oct 02.
Typ publikacji :: Practice Guideline
MeSH Terms :: Arthritis, Psoriatic*/drug therapy
Arthritis, Psoriatic*/epidemiology
Psoriasis*/drug therapy
Psoriasis*/epidemiology
Antirheumatic Agents/therapeutic use ; Humans ; Rheumatology ; Taiwan/epidemiology

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?
Autorzy :: Singh MK; CSIR-Institute of Genomics and Integrative Biology, New Delhi, 110007, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
Mobeen A; CSIR-Institute of Genomics and Integrative Biology, New Delhi, 110007, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
Chandra A; CSIR-Institute of Genomics and Integrative Biology, New Delhi, 110007, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
Joshi S; Jamia Hamdard, Hamdard Nagar, New Delhi, 110062, India.
Ramachandran S; CSIR-Institute of Genomics and Integrative Biology, New Delhi, 110007, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. Electronic address: .; Pokaż więcej
Źródło :: Computers in biology and medicine [Comput Biol Med] 2021 Mar; Vol. 130, pp. 104219. Date of Electronic Publication: 2021 Jan 16.
Typ publikacji :: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :: Angiotensin-Converting Enzyme 2/*biosynthesis
COVID-19/*metabolism
Diabetes Mellitus, Type 2/*metabolism
Neoplasm Proteins/*metabolism
Neoplasms/*metabolism
Non-alcoholic Fatty Liver Disease/*metabolism
Psoriasis/*metabolism
Pulmonary Arterial Hypertension/*metabolism
SARS-CoV-2/*metabolism
COVID-19/mortality ; Comorbidity ; Diabetes Mellitus, Type 2/mortality ; Gene Expression Regulation, Neoplastic ; Gene Expression Regulation, Viral ; Humans ; Neoplasms/mortality ; Non-alcoholic Fatty Liver Disease/mortality ; Psoriasis/mortality ; Pulmonary Arterial Hypertension/mortality ; Signal Transduction
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data.
Autorzy :: de Wijs LEM; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Joustra MM; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Olydam JI; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Nijsten T; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Hijnen DJ; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.; Pokaż więcej
Źródło :: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2021 Mar; Vol. 35 (3), pp. e173-e176. Date of Electronic Publication: 2020 Nov 22.
Typ publikacji :: Letter; Observational Study
MeSH Terms :: COVID-19/*immunology
Dermatitis, Atopic/*immunology
Psoriasis/*immunology
Adult ; COVID-19/epidemiology ; Cross-Sectional Studies ; Dermatitis, Atopic/epidemiology ; Dermatitis, Atopic/psychology ; Female ; Humans ; Male ; Middle Aged ; Netherlands/epidemiology ; Pandemics ; Psoriasis/epidemiology ; Psoriasis/psychology ; SARS-CoV-2 ; Surveys and Questionnaires
: Raport

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: The effect of moving cupping on psoriasis vulgaris and its influence on PASI score: A protocol for systematic review and meta-analysis.
Autorzy :: Yunbo W; Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine.
Mingqiang L; Jiangxi University of traditional Chinese medicine, 56 Yangming Road, Donghu District, Nanchang City, Jiangxi Province, PR China.
Guirong Q; Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine.
Hongrong L; Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine.
Gang H; Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine.; Pokaż więcej
Źródło :: Medicine [Medicine (Baltimore)] 2021 Feb 12; Vol. 100 (6), pp. e24217.
Typ publikacji :: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :: Cupping Therapy/*methods
Medicine, Chinese Traditional/*methods
Psoriasis/*therapy
China/epidemiology ; Cupping Therapy/adverse effects ; Female ; Humans ; Male ; Medicine, Chinese Traditional/adverse effects ; Psoriasis/epidemiology ; Psoriasis/pathology ; Quality of Life ; Randomized Controlled Trials as Topic ; Risk Assessment ; Safety ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specific clinical and comorbid situations.
Autorzy :: Nast A; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Department of Dermatology, Venereology and Allergology, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Smith C; St John's Institute of Dermatology, London, UK.
Spuls PI; Academic Medical Centre Amsterdam, Amsterdam, Netherlands.
Avila Valle G; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Department of Dermatology, Venereology and Allergology, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Bata-Csörgö Z; University of Szeged, Szeged, Hungary.
Boonen H; Office-Based Dermatology Practice, Geel, Belgium.
De Jong E; Radboud University Medical Centre Nijmegen, Nijmegen, Netherlands.
Garcia-Doval I; Unidad de Investigación. Fundación Piel Sana AEDV, Madrid, Spain.
Gisondi P; University of Verona, Verona, Italy.
Kaur-Knudsen D; University Hospital Copenhagen, Copenhagen, Denmark.
Mahil S; Guy's and St Thomas' NHS Foundation Trust, London, UK.
Mälkönen T; Helsinki University Central Hospital, Helsinki, Finland.
Maul JT; Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland.
Mburu S; International Federation of Psoriasis Associations (IFPA).
Mrowietz U; Universitätsklinikum Schleswig-Holstein, Kiel, Germany.
Reich K; Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Remenyik E; University of Debrecen, Debrecen, Hungary.
Rønholt KM; Aarhus University Hospital, Aarhus, Denmark.
Sator PG; Municipal Hospital Hietzing, Vienna, Austria.
Schmitt-Egenolf M; Dermatology, Department of Public Health & Clinical Medicine, Umeå University, Umeå, Sweden.
Sikora M; Department of Dermatology, Medical University of Warsaw, Warsaw, Poland.
Strömer K; Office-Based Dermatology Practice, Mönchengladbach, Germany.
Sundnes O; Oslo University Hospital, Oslo, Norway.
Trigos D; International Federation of Psoriasis Associations (IFPA).
Van Der Kraaij G; Academic Medical Centre Amsterdam, Amsterdam, Netherlands.
Yawalkar N; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Dressler C; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Department of Dermatology, Venereology and Allergology, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Pokaż więcej
Źródło :: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2021 Feb; Vol. 35 (2), pp. 281-317.
Typ publikacji :: Journal Article; Practice Guideline
MeSH Terms :: Psoriasis/*complications
Psoriasis/*therapy
Humans ; Psoriasis/psychology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: A nuclear factor kappa B reporter cell line used to evaluate ex vivo the net inflammatory effect of plasma samples from patients with rheumatoid arthritis, psoriasis, or COVID-19.
Autorzy :: Wagner L; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Haefeli WE; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Merle U; Department of Gastroenterology and Hepatology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Lorenz HM; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Hohmann N; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Weiss J; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Theile D; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany. Electronic address: .; Pokaż więcej
Źródło :: Cytokine [Cytokine] 2021 Feb; Vol. 138, pp. 155399. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji :: Journal Article
MeSH Terms :: Arthritis, Rheumatoid/*pathology
COVID-19/*pathology
NF-kappa B/*blood
NF-kappa B/*metabolism
Psoriasis/*pathology
Arthritis, Rheumatoid/blood ; C-Reactive Protein/analysis ; Cell Line ; Enzyme Activation/physiology ; Female ; HEK293 Cells ; Humans ; Inflammation/pathology ; Inflammation Mediators/metabolism ; Male ; Middle Aged ; Psoriasis/blood ; SARS-CoV-2/immunology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Psoriasis Associated With Tumor Necrosis Factor Inhibitors in Children With Inflammatory Diseases.
Autorzy :: Buckley LH; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, and Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee.
Xiao R; Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia.
Perman MJ; Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Grossman AB; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Weiss PF; Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia.; Pokaż więcej
Źródło :: Arthritis care & research [Arthritis Care Res (Hoboken)] 2021 Feb; Vol. 73 (2), pp. 215-220. Date of Electronic Publication: 2021 Jan 03.
Typ publikacji :: Journal Article
MeSH Terms :: Arthritis, Juvenile/*drug therapy
Inflammatory Bowel Diseases/*drug therapy
Osteomyelitis/*drug therapy
Psoriasis/*chemically induced
Tumor Necrosis Factor Inhibitors/*adverse effects
Adolescent ; Age Factors ; Arthritis, Juvenile/diagnosis ; Arthritis, Juvenile/immunology ; Child ; Chronic Disease ; Databases, Factual ; Female ; Humans ; Incidence ; Inflammatory Bowel Diseases/diagnosis ; Inflammatory Bowel Diseases/immunology ; Male ; Osteomyelitis/diagnosis ; Osteomyelitis/immunology ; Psoriasis/diagnosis ; Psoriasis/epidemiology ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Model to Determine the Cost-Effectiveness of Screening Psoriasis Patients for Psoriatic Arthritis.
Autorzy :: Iragorri N; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Hazlewood G; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Manns B; Cumming School of Medicine, University of Calgary, Calgary, and Alberta Health Services, Edmonton, Alberta, Canada.
Bojke L; University of York, York, UK.
Spackman E; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Pokaż więcej
Corporate Authors :: Early Detection to Improve Outcome in People With Undiagnosed Psoriatic Arthritis Study Group
Źródło :: Arthritis care & research [Arthritis Care Res (Hoboken)] 2021 Feb; Vol. 73 (2), pp. 266-274.
Typ publikacji :: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Health Care Costs*
Arthritis, Psoriatic/*diagnosis
Arthritis, Psoriatic/*economics
Diagnostic Screening Programs/*economics
Psoriasis/*diagnosis
Psoriasis/*economics
Surveys and Questionnaires/*economics
Antirheumatic Agents/economics ; Antirheumatic Agents/therapeutic use ; Arthritis, Psoriatic/drug therapy ; Biological Products/economics ; Biological Products/therapeutic use ; Cost Savings ; Cost-Benefit Analysis ; Disability Evaluation ; Drug Costs ; Early Diagnosis ; Female ; Humans ; Male ; Markov Chains ; Middle Aged ; Models, Economic ; Predictive Value of Tests ; Psoriasis/drug therapy ; Quality of Life ; Quality-Adjusted Life Years
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""psoriasis"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język